서울대학교 의과대학 임상약리학교실

Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects

Tan B, Naik H, Jang IJ, Yu KS, Kirsch LE, Shin CS, Craft JC, Fleckenstein L.

Malar J 2009,Jan;8(1): 304

Pharmacokinetics and pharmacodynamics of LC15-0444, a novel dipeptidyl peptidase IV inhibitor, after multiple dosing in healthy volunteers

Lim KS, Cho JY, Kim BH, Kim JR, Kim HS, Kim DK, Kim SH, Yim HJ, Lee SH, Shin SG, Jang IJ, Yu KS.

Br J Clin Pharmacol 2009,Jan;68(6): 883-90

The effects of ketoconazole and rifampicin on the pharmacokinetics of mirodenafil in healthy Korean male volunteers: an open-label, one-sequence, three-period, three-treatment crossover study

Shin KH, Kim BH, Kim TE, Kim JW, Yi SJ, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.

Clin Ther 2009,Jan;3009-3020

Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: an open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers

Lee SH, Chung YJ, Kim BH, Shim JH, Yoon SH, Shin SG , Jang IJ, Yu KS.

Clin Ther 2009,Jan;3000-3008

Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single- dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers

Kim BH, Shin KH, KIm JW, Lim KS, Kim KP, Kim JR, Cho JY, Shin SG, Jang IJ, Yu KS.

Clin Ther 2009,Jan;2755-2764

Potential interactions between cilostazol and probucol: a two-part, single-dose, open-label study in healthy Korean male volunteers

Kim KP, Kim BH, Lim KS, Kim TE, Shin SG, Jang IJ, Yu KS.

Clin Ther 2009,Jan;31(10): 2098-106

Comparison of The pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: An open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy korean male volunteers

Kim TE, Kim BH, Kim J, Kim KP, Yi S, Shin HS, Lee YO, Lee KH, Shin SG, Jang IJ, Yu KS.

Clin Ther 2009,Jan;31(10): 2249-57

Pharmacokinetics of intravenous piperacillin administration in patients undergoing on-line hemodiafiltration

Oh KH, Kim C, Lee H, Lee H, Jung JY, Kim NJ, Yu KS, Shin KH, Jang IJ, Ahn C.

Antimicrob Agents Chemother 2009,Jan;53(8): 3266-8

Effect of food on the pharmacokinetics of the oral phosphodiesterase 5 inhibitor udenafil for the treatment of erectile dysfunction

Kim TE, Kim BH, Kim JR, Lim KS, Hong JH, Kim KP, Kim HS, Shin SG, Jang IJ, Yu KS.

Br J Clin Pharmacol 2009,Jan;68(1): 43-6

Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in Korea

Kim BH, Yi S, Kim J, Lim KS, Kim KP, Lee B, Shin SG, Jang IJ, Yu KS.

Clin Ther 2009,Jan;31(6): 1234-43

Effects of angelicae tenuissima radix, angelicae dahuricae radix and scutellariae radix extracts on cytochrome P450 activities in healthy volunteers

Yi S, Cho JY, Lim KS, Kim KP, Kim J, Kim BH, Hong JH, Jang IJ, Shin SG, Yu KS.

Basic Clin Pharmacol Toxicol 2009,Jan;105: 249-256

An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects

Kim BH, Kim JR, Lim KS, Kim JW, Kim KP, Hong JH, Jang IJ, Shin SG, Yu KS, Tanaka T.

Clin Ther 2009,Jan;31(3): 609-618

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy

Kim DW, Lee SK, Chu K, Jang IJ, Yu KS, Cho JY, Kim SJ.

Epilepsy Res 2009,Jan;84(1): 86-90

Genetic polymorphisms of drug-metabolizing enzymes and anti-TB drug-induced hepatitis

Kim SH, Kim SH, Bahn JW, Kim YK, Chang YS, Shin ES, Kim YS, Park JS, Kim BH, Jang IJ, Song J, Kim SH, Park HS, Min KU, Jee YK.

Pharmacogenomics 2009,Jan;10(11): 1767-79

Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea

Choi KD, Kim N, Jang IJ, Park YS, Cho JY, Kim JR, Shin JM, Jung HC, Song IS.

J Gastroenterol Hepatol 2009,Jan;24(10): 1617-24

Synergistic anti-tumor efficacy of lovastatin and protein kinase C-beta inhibitor in hepatocellular carcinoma

Kim W, Yoon JH, Kim JR, Jang IJ, Bang YJ, Kim YJ, Lee HS.

Cancer Chemother Pharmacol 2009,Jan;64(3): 497-507

Association between tumor necrosis factor alpha 308G/a polymorphism and increased proinflammatory cytokine release after cardiac surgery with cardiopulmonary bypass in the Korean population

Yoon SZ, Jang IJ, Choi YJ, Kang MH, Lim HJ, Lim YJ, Lee HW, Chang SH, Yoon SM.

J Cardiothorac Vasc Anesth 2009,Jan;23(5): 646-50

Pharmacokinetics of hydroxychloroquine and its clinical implications in the chemoprophylaxis malaria caused by plasmodium vivax

Lim HS, Im JS, Cho JY, Bae KS, Klein TA, Yeom JS, Kim TS, Choi JS, Jang IJ, Park JW.

Antimicrob Agents Chemother 2009,Jan;(4)

Gastroprotective action of cochinchina momordica seed extract is medicted by activation of CGRP and inhibition of cPla(2)/5-LOX pathway

Kang JM, Kim N, Kim B, Kim JH, Lee BY, Park JH, Lee MK, Lee HS, Jang IJ, Kim JS, Jung HC, Song IS

Dig Dis Sci 2009,Jan;(1)